May 6 |
OrthoPediatrics Non-GAAP EPS of -$0.30 beats by $0.09, revenue of $44.7M beats by $2.93M
|
May 6 |
OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates
|
May 6 |
OrthoPediatrics Corp. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance
|
May 2 |
OrthoPediatrics Corp. Receives “Breakthrough Device” Designation from FDA for eLLi™ Growing Rod System for Pediatric Patients with Scoliosis
|
Apr 22 |
OrthoPediatrics Corp. to Report First Quarter 2024 Financial Results on May 7, 2024
|
Apr 10 |
The Analyst Verdict: OrthoPediatrics In The Eyes Of 6 Experts
|
Apr 4 |
OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 8th Annual International Children’s Spine Symposium (ICSS)
|
Mar 26 |
OrthoPediatrics Corp. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
|
Mar 15 |
OrthoPediatrics files $250M mixed securities shelf
|
Mar 12 |
OrthoPediatrics Corp. (NASDAQ:KIDS) Q4 2023 Earnings Call Transcript
|